NCT03513484 2025-10-21Nintedanib and Azacitidine in Treating Participants With HOX Gene Overexpression Relapsed or Refractory Acute Myeloid LeukemiaNorthwestern UniversityPhase 1 Active not recruiting44 enrolled
NCT02665143 2022-04-08A Randomized Trial of a Combination of Nintedanib/Placebo in Combination With Induction Chemotherapy for Patients With Refractory or First Relapse Acute Myeloid LeukemiaYale UniversityPhase 2 Completed25 enrolled 7 charts